Cargando…
Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949485/ https://www.ncbi.nlm.nih.gov/pubmed/31916402 http://dx.doi.org/10.15252/emmm.201911749 |
_version_ | 1783485915455291392 |
---|---|
author | Mohlin, Sofie Hansson, Karin Radke, Katarzyna Martinez, Sonia Blanco‐Aparicio, Carmen Garcia‐Ruiz, Cristian Welinder, Charlotte Esfandyari, Javanshir O'Neill, Michael Pastor, Joaquin von Stedingk, Kristoffer Bexell, Daniel |
author_facet | Mohlin, Sofie Hansson, Karin Radke, Katarzyna Martinez, Sonia Blanco‐Aparicio, Carmen Garcia‐Ruiz, Cristian Welinder, Charlotte Esfandyari, Javanshir O'Neill, Michael Pastor, Joaquin von Stedingk, Kristoffer Bexell, Daniel |
author_sort | Mohlin, Sofie |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6949485 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69494852020-01-10 Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma Mohlin, Sofie Hansson, Karin Radke, Katarzyna Martinez, Sonia Blanco‐Aparicio, Carmen Garcia‐Ruiz, Cristian Welinder, Charlotte Esfandyari, Javanshir O'Neill, Michael Pastor, Joaquin von Stedingk, Kristoffer Bexell, Daniel EMBO Mol Med Corrigendum John Wiley and Sons Inc. 2020-01-09 2020-01-09 /pmc/articles/PMC6949485/ /pubmed/31916402 http://dx.doi.org/10.15252/emmm.201911749 Text en © 2019 The Authors. Published under the terms of the CC BY 4.0 license This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Corrigendum Mohlin, Sofie Hansson, Karin Radke, Katarzyna Martinez, Sonia Blanco‐Aparicio, Carmen Garcia‐Ruiz, Cristian Welinder, Charlotte Esfandyari, Javanshir O'Neill, Michael Pastor, Joaquin von Stedingk, Kristoffer Bexell, Daniel Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma |
title | Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma |
title_full | Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma |
title_fullStr | Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma |
title_full_unstemmed | Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma |
title_short | Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma |
title_sort | anti‐tumor effects of pim/pi3k/mtor triple kinase inhibitor ibl‐302 in neuroblastoma |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949485/ https://www.ncbi.nlm.nih.gov/pubmed/31916402 http://dx.doi.org/10.15252/emmm.201911749 |
work_keys_str_mv | AT mohlinsofie antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma AT hanssonkarin antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma AT radkekatarzyna antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma AT martinezsonia antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma AT blancoapariciocarmen antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma AT garciaruizcristian antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma AT welindercharlotte antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma AT esfandyarijavanshir antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma AT oneillmichael antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma AT pastorjoaquin antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma AT vonstedingkkristoffer antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma AT bexelldaniel antitumoreffectsofpimpi3kmtortriplekinaseinhibitoribl302inneuroblastoma |